FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease

(MedPage Today) — The first FDA-approved treatment option for Sjögren’s disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data.
B-cell activation in Sjögren’s disease results in immunoglobulin…

Source link : https://www.medpagetoday.com/spotlight/acr-sjogrens-syndrome/119151

Author :

Publish date : 2025-12-23 13:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FcRn Blockers Vie to Become First Approved Drug for Sjogren’s Disease

EU Calls for Heart Health Plans Amid Rising Disease Burden

The best space pictures of 2025, from supernovae to moon landings

Related Posts

Single-Pill Approach Proves Beneficial in Hypertension

Alzheimer’s Paper Retracted; Lipoic Acid and MS; Botched Autism Drug Rollout

Assessing Non-Glandular Manifestations of Sjogren’s Disease

Prediabetes Reversal Benefits; Many Seniors Quit GLP-1s in a Year; Testosterone Fads

The Midterms Are Coming. Vaccines May Play a Role.

Six-Monthly HIV Prevention Injection Cleared by MHRA

Single-Pill Approach Proves Beneficial in Hypertension

Alzheimer’s Paper Retracted; Lipoic Acid and MS; Botched Autism Drug Rollout

Assessing Non-Glandular Manifestations of Sjogren’s Disease

Prediabetes Reversal Benefits; Many Seniors Quit GLP-1s in a Year; Testosterone Fads

The Midterms Are Coming. Vaccines May Play a Role.

Six-Monthly HIV Prevention Injection Cleared by MHRA

Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest

‘Armored’ CAR T Cells Show Early Promise in Relapsed B-Cell ALL

Categories

Archives